Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$6.59M Buy
144,800
+37,200
+35% +$1.81M ﹤0.01% 1776
2014
Q2
$5.55M Buy
107,600
+74,800
+228% +$3.68M ﹤0.01% 1864
2014
Q1
$1.6M Sell
32,800
-8,800
-21% -$427K ﹤0.01% 3003
2013
Q4
$1.8M Buy
41,600
+29,100
+233% +$1.2M ﹤0.01% 2904
2013
Q3
$477K Buy
12,500
+7,500
+150% +$264K ﹤0.01% 4192
2013
Q2
$155K Buy
+5,000
New +$149K ﹤0.01% 5381

Other funds holding VTRS

UBS's VTRS Position: Q3 2014 in Review

UBS increased its Viatris (VTRS) stake by 41% in Q3 2014, buying an estimated $15M and bringing the position to 1,058,091 shares worth $48.1M. The position accounts for 0.04% of the portfolio, ranked #526.

UBS first reported a position in VTRS in Q2 2013 and has held it in 6 quarters since. 629 funds tracked by Wall St. Rank hold VTRS as of Q3 2014.

  • UBS held 1,058,091 shares of Viatris worth $48.1M as of Q3 2014.
  • UBS bought 307,893 Viatris shares in Q3 2014, an estimated $15M.
  • Viatris made up 0.04% of UBS's portfolio in Q3 2014, its #526 holding.
  • UBS first reported a position in Viatris in Q2 2013 and has held it in 6 quarters since.
  • 629 funds tracked by Wall St. Rank held Viatris as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.